Evidence map›Paper›PMID 38283349›Full record

ArticleFrontiers in immunology2023

Bidirectional Mendelian randomization analysis investigating the genetic association between primary breast cancer and colorectal cancer.

Yi Liu, Mingxuan Si, Yawei Qian, Yang Liu, Zichen Wang, Tongyu Zhang, Zhenhuan Wang, Kun Ye, Cuijuan Xiang, Linlin Xu and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Clinical utility of metagenomic next-generation sequencing in diagnosing spinal infections: a systematic review and meta-analysis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yi Liu *Department of Digestive System, Anqing Municipal Hospital, Anqing, China.
Mingxuan Si *Department of Thoracic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yawei Qian *Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yang LiuSchool of Economics and Management, Wuhan University, Wuhan, China.
Zichen WangDepartment of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Tongyu ZhangDepartment of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhenhuan WangDepartment of Digestive System, Anqing Municipal Hospital, Anqing, China.
Kun YeDepartment of Digestive System, Anqing Municipal Hospital, Anqing, China.
Cuijuan XiangDepartment of Digestive System, Anqing Municipal Hospital, Anqing, China.
Linlin XuDepartment of Digestive System, Anqing Municipal Hospital, Anqing, China.
Yanping ZhangDepartment of Digestive System, Anqing Municipal Hospital, Anqing, China.
Zhihan XiaoDepartment of Cardiothoracic Surgery, Wuhu Second People's Hospital, Wuhu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: With the advancement in early diagnosis and treatment, the prognosis for individuals diagnosed with breast cancer (BC) has improved significantly. The prognosis of primary breast cancer (PBC) survivors can be significantly influenced by the occurrence of colorectal cancer (CRC) as a secondary primary cancer (SPC). The objective of this study is to explore the possible genetic association between PBC and CRC, aiming to lay a groundwork for the development of preventive strategies against SPC-CRC following BC surgery. Methods: We employed a bidirectional two-sample Mendelian randomization (MR) approach to thoroughly examine genetic instrumental variables (IVs) derived from genome-wide association studies (GWAS) conducted on PBC and CRC. And applied inverse variance weighted (IVW) and multiple other MR methods (weighted median, simple median, MR-PRESSO and MR-RAPS) to evaluate the association between the two cancers (PBC and CRC) at genetic level. Furthermore, the robustness of the findings was further confirmed through the utilization of the genetic risk score (GRS) method in a secondary analysis. Results: Forward MR analysis, a total of 179 BC genetic IVs, 25 estrogen receptor-negative (ER-) genetic IVs and 135 ER-positive (ER+) genetic IVs were screened. Reverse MR analysis, 179 genetic IVs of CRC, 25 genetic IVs of colon cancer, 135 genetic IVs of rectal cancer, 25 genetic IVs of left colon cancer and 135 genetic IVs of right colon cancer were screened. IVW and other MR methods found no significant genetic association between PBC and CRC ( Conclusions: Our findings do not provide any evidence supporting the association between PBC and CRC at the genetic level. Further large-scale prospective studies are warranted to replicate our findings.

Indexed as

Breast NeoplasmsColonic NeoplasmsNeoplasms, Second PrimaryFemaleGenetic Risk ScoreGenome-Wide Association StudyHumansMendelian Randomization AnalysisReproducibility of Resultsbreast cancercolorectal cancerGRSGWASMendelian randomization

Identifiers

PMID38283349
PMCPMC10811019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.